| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
| There are 8 registered members and 96 guests viewing the site. | Follow us on Twitter | Rss Top Picks Feed | Rss Daily Feed |
|
| TOP PICK | 99.640 | Ian Ainsworth | Irish pharmaceutical company and its major franchise is Adderall for attention deficit disorder. The opportunity here is that they can move it into adults. The other part of their business is orphan drugs, drugs that are not targets for large pharmaceuticals. | 2012-02-01 | |
| TOP PICK | 56.140 | Ian Ainsworth | (A Top Pick Jan 26/05. Up 11%.) Pharma company that’s moving into the biotech space. Have a lot of new products. Does $1.9 billion in revenues and can add another $1.4 billion incremental revenues in the next 4-5 years if the products are approved. | 2006-11-09 | |
| TOP PICK | 47.630 | Ian Ainsworth | A UK company that does such nervous system pharmaceutical products. The big product is for hyperactive disorder. Adderall, a big seller, does not become generic for three years. Multiple in the high teens. Also has five new products coming out. | 2006-01-26 |